BMI View: We calculate that the Thai pharmaceutical market will post a five-year compound annual growth rate (CAGR) of 5.7% in local currency terms, or of 7.0% in US dollars, to reach THB178.54bn (US $6.10bn) in 2017. Key drivers of growth will be volume-based, as the government continues to prioritise the use of generic medicines. Nevertheless, regional harmonisation initiatives – in addition to ongoing trade negotiations – are expected to gradually remove some of the market access barriers for novel products, though their uptake will remain dependent on the availability of private funding. Headline Expenditure Projections ? Pharmaceuticals: THB135.38bn (US$4.36bn) …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=127502.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/thailand-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment